Cutaneous Anthrax: What is the Hallmark?
Abstract
A 71-year-old man complained of a blackish wound under his left eye, which began with fever and reddish spots after helping to slaughter a cow and cut its meat. The fever occured especially in the afternoon to evening, and is not accompanied by chills and sweating. On day 4 of fever onset, the fever diminished and the spots progressively widened with swelling. On day 7, the lesions on the skin became open wounds that were not purulent and did not bleed. On day 9, a blackish, painless layer appeared over the wounds and widened, further covering their surface. Upon presentation, the patient’s general condition was good, with normal vital signs and temperature. He presented with a solitary ulcer accompanied by edema, sized 1 cm x 3 cm, not hyperemic, firm border, flat edge, and covered with blackish eschar.
Blood tests revealed normal levels of hemoglobin, leukocyte, platelets, kidney and liver function. The anti-anthrax protective antigen (anti-PA) IgG level is found to be seropositive with a level of 85 U/ml. Gram staining of the tissue underneath the eschar found Gram-positive rod bacteria in reddish-purple color. The patient was clinically diagnosed with probable cutaneous anthrax, and was treated with amoxicillin 500 mg orally t.i.d. for three days and paracetamol 500 mg if fever developed. The tissue sample was sent to a laboratory with Bio Safety level 3 facilities for microbiological culture, with the results of Bacillus anthracis growth. On day three after antibiotic administration, the wound was smaller (0.5 cm x 1.5 cm), firm border, flat edge, with a bit of edema above it. The eschar was thickened, painless, not purulent nor bleeding. Antibiotic administration is continued for another three days with amoxicillin 500 mg orally t.i.d. On day 6 of antibiotic administration, the eschar began to peel off, and antibiotics were stopped. On the 10th day, the eschar peeled off entirely without leaving a mark.
Early diagnosis is crucial in preventing the spread that may lead to more cases. Clinical and serological examinations are the spearheads of early detection of anthrax cases. Prompt and appropriate management largely determines the success of therapy.
Keywords
References
Mahmoudi H. Cutaneous anthrax in a farmer man: A case report. Open Microbiol J. 2022;16(1):2–4.
Doganay M, Dinc G, Kutmanova A, Baillie L. Human anthrax: Update of the diagnosis and treatment. Diagnostics (Basel). 2023;13(6):1056.
Savransky V, Ionin B, Reece J. Current status and trends in prophylaxis and management of anthrax disease. Pathogens. 2020; 9(5):370.
Riswanto R, Redhono D, Nurhayatun E. Antraks kulit di Gunung Kidul, Yogyakarta: Laporan kasus. J Penyakit Dalam Indonesia. 2021;8(3):151.
Redhono D, Agung N, Andika F, Sunarso I, Kusumawardani A, Dasa A. Indirect contact increases antibody titers in people exposed to anthrax. GSC Biological and Pharmaceutical Sciences. 2023; 25(02):405–10.
Celik E, Gonen T. Cutaneous anthrax on the upper eyelid. Case Rep Ophthalmol. 2021;12(3):836–40.
Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. American Journal of Respiratory and Critical Care Medicine. 2011;184(12):1333-41.
Liu Y, Zheng G, Li J, et al. A case report of cutaneous anthrax diagnosed by using a metagenomic next-generation sequencing (mNGS) approach. Infect Drug Resist. 2023;16:3601–6.
Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. Journal of Infection and Public Health. 2010;3(3):98-105.
Refbacks
- There are currently no refbacks.